Skip to main content

Table 1 Baseline characteristics

From: Benefits of whole body vibration training in patients hospitalised for COPD exacerbations - a randomized clinical trial

Measured parameter Control WBV p-value
Gender [M/F] 12/8 14/6 0.74
Age [years] 70.4 ± 10.1 66.4 ± 9.93 0.24
Height [cm] 170.3 ± 10.63 168.9 ± 9.28 0.5
Weight [kg] 75.15 ± 19.73 79.5 ± 23.48 0.7
BMI [kg/m 2 ] 25.75 ± 6.42 27.88 ± 7.87 0.51
FEV 1 [% pred.] 38.4 ± 17.82 32.71 ± 13.18 0.43
GOLD stages [I/II/III/IV) 1/4/7/7 0/1/11/8 0.3
Current Smokers [%] 26.23 30 1.00
Mean Packyears* 47,50 ± 35,94 39,64 ± 27,91 0.53
On ICS before study [%] 64.29 70.59 1.00
On OCS before study [%] 14.29 23.53 0.66
Antibiotics [yes/no] 8/12 11/9 0.53
  1. Data are displayed as mean ± standard deviation. There were no statistical differences between both groups. Mann–Whitney-U test was used to compare ordinal variables, categorial variables (gender, GOLD stages and antibiotics) were tested using the Exact Fisher test. BMI: Body mass index; FEV1: Forced exspiratory volume in one second; ICS: inhaled corticosteroids; OCS: Oral corticosteroids.